(Z)-5-(2-cyclohexyl-2-(6-(8-fluoronaphthalen-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)ethylidene)oxazolidine-2,4-dione

ID: ALA4757179

PubChem CID: 137477635

Max Phase: Preclinical

Molecular Formula: C26H23FN2O4

Molecular Weight: 446.48

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1NC(=O)/C(=C/C(c2ccc(-c3ccc4cccc(F)c4c3)[nH]c2=O)C2CCCCC2)O1

Standard InChI:  InChI=1S/C26H23FN2O4/c27-21-8-4-7-16-9-10-17(13-20(16)21)22-12-11-18(24(30)28-22)19(15-5-2-1-3-6-15)14-23-25(31)29-26(32)33-23/h4,7-15,19H,1-3,5-6H2,(H,28,30)(H,29,31,32)/b23-14-

Standard InChI Key:  RLHWDWIGTXQJCD-UCQKPKSFSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    4.4822  -18.2217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1962  -18.6303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1962  -19.4475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9015  -19.8520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6067  -19.4475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6067  -18.6303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9015  -18.2176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4891  -19.8571    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3120  -19.8561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3095  -20.6744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0158  -21.0839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0168  -19.4490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7236  -19.8549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7224  -20.6756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4314  -21.0852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1422  -20.6753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1394  -19.8514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4298  -19.4455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4275  -18.6283    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.4797  -17.4039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7693  -17.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6742  -16.1897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8738  -16.0251    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4699  -16.7355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0208  -17.3391    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6577  -16.8264    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2764  -15.6372    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7778  -18.6346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0689  -18.2262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3647  -18.6337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3632  -19.4513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0722  -19.8596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7826  -19.4504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  2  7  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  1  1  0
  3  8  2  0
  9 10  2  0
 10 11  1  0
 11 14  2  0
 13 12  2  0
 12  9  1  0
  5  9  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 18 19  1  0
  1 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 21  1  0
 24 26  2  0
 22 27  2  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
  1 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4757179

    ---

Associated Targets(Human)

PTGER3 Tclin Prostanoid EP3 receptor (1985 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.48Molecular Weight (Monoisotopic): 446.1642AlogP: 5.15#Rotatable Bonds: 4
Polar Surface Area: 88.26Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 6.15CX Basic pKa: CX LogP: 4.01CX LogD: 2.82
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.54Np Likeness Score: -0.37

References

1. Zhang X,Zhu B,Guo L,Bakaj I,Rankin M,Ho G,Kauffman J,Lee SP,Norquay L,Macielag MJ.  (2021)  Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes.,  12  (3): [PMID:33738072] [10.1021/acsmedchemlett.0c00667]

Source